Integrating Comprehensive and Alternative Medicine into stroke. Herbal Treatment of Ischemia

Complementary and Alternative Therapies and the Aging Population

Volumn , Issue , 2009, Pages 229-274

  Lin, Baowan ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882824475     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-374228-5.00012-3     Document Type: Chapter

References (174)

1. Hachinski V. Stroke and vascular cognitive impairment. Stroke 2007, 38:1396-1403.
2. Ginsberg M.D. Adventures in the pathophysiology of brain ischemia: Penumbra, gene expression, neuroprotection: The 2002 Thomas Willis Lecture. Stroke 2003, 34:214-223.
3. Lo E.H., Dalkara T., Moskowitz M.A. Mechanisms, challenges and opportunities in stroke. Nature Rev Neurosci 2003, 4:399-414.
4. Cheng Y.D., Al-Khoury L., Zivin J.A. Neuroprotection for ischemic stroke: Two decades of success and failure. Neuro Rx 2004, 1:36-45.
5. Moskowitz M.A., Lo E.H. Neurogenesis and apoptotic cell death. Stroke 2003, 34:324-326.
6. Jin K., Peel A.L., Mao X.O., Xie L., Cottrell B.A., Henshall D.C., Greenberg D.A. Increased hippocampal neurogenesis in Alzheimer's disease. PNAS 2004, 101:343-347.
7. Gong X., Sucher N.J. Stroke therapy in traditional Chinese medicine (TCM): Prospects for drug discovery and development. Phytomedicine 2002, 9:478-484.
8. Kim H. Neuroprotective herbs for stroke therapy in traditional eastern medicine. Neurological Res 2005, 27:287-301.
9. Shi F.L., Hart R.G., Sherman D.G., et al. Stroke in the people's republic of China. Stroke 1989, 20:1581-1585.
10. Mena H., Cadavid D., Rushing E.J. Human cerebral infarct: A proposed histopathologic classification based on 137 cases. Acta Neuropathol 2004, 108:524-530.
11. Schiemanck S.K., Post M.W., Witkamp T.D., Kappelle L.J., Prevo A.J. Relationship between ischemic lesion volume and functional status in the 2nd week after middle cerebral artery stroke. Neurorehabil Neural Repair 2005, 19:133-138.
12. Tatemichi T.K., Paik M., Bagiella E., Desmond D.W., Pirro M., Hanzawa L.K. Dementia after stroke is a predictor of long-term survival. Stroke 1994, 25:1915-1919.
13. Tatemichi T.K., Paik M., Bagiella E., Desmond D.W., Stern Y., Sano M., Hauser W.A., Mayeux R. Risk of dementia after stroke in a hospitalized cohort: Results of a longitudinal study. Neurology 1994, 44:1885-1891.
14. Jendroska K., Poewe W., Daniel S.E., Pluess J., Iwerssen-Schmidt H., Paulsen J., Barthel S., Schelosky L., Cervos-Navarro J., DeArmond S.J. Ischemic stress induces deposition of amyloid beta immunoreactivity in human brain. Acta Neuropathol. 1995, 90:461-466.
15. Garcia J.H., Liu K.F., Ye Z.R., Gutierrez J.A. Incomplete infarct and delayed neuronal death after transient middle cerebral artery occlusion in rats. Stroke 1997, 28:2303-2310.
16. Butler T.L., Kassed C.A., Sanberg P.R., Willing A.E., Pennypacker K.R. Neurodegeneration in the rat hippocampus and striatum after middle cerebral artery occlusion. Brain Res. 2002, 929:252-260.
17. Dihne M., Grommes C., Lutzenburg M., Witte O.W., Block F. Different mechanisms of secondary neuronal damage in thalamic nuclei after focal cerebral ischemia in rats. Stroke 2002, 33:3006-3011.
18. Lin B., Ginsberg M.D. Quantitative assessment of the normal microvasculature by endothelial barrier antigen (EBA) immunohistochemistry: Application to focal cerebral ischemia. Brain Res 2000, 865:237-244.
19. Nishigaya K., Yagi S., Sato T., Kanemaru K., Nukui H. Impairment and restoration of the endothelial blood-brain barrier in the rat cerebral infarction model assessed by expression of endothelial barrier antigen immunoreactivity. Acta Neuropathol 2000, 99:231-237.
20. Garcia J.H., Liu K.F., Yoshida Y., Chen S., Lian J. Brain microvessel: Factors altering their patency after the occlusion of a middle cerebral artery (Wistar rat). Am J Pathol 1994, 145:728-740.
21. Garcia J.H., Liu K.F., Yoshida Y., Lian J., Chen S., del Zoppo G.J. Influx of leukocytes and platelets in an evolving brain infarct (Wistar rat). Am J Pathol 1994, 144:188-199.
22. Heye N., Paetzold C., Cerbos-Navarro J. The role of microthrombi and microcirculatory factors in localization and evolution of focal cerebral ischemia. Neurosurg Rev 1991, 14:7-16.
23. Zhang Z.G., Zhang L., Tsang W., Goussev A., Powers C., Ho K.L., Morris D., Smyth S.S., Coller B.S., Chopp M. Dynamic platelet accumulation at the site of the occluded middle cerebral artery and in downstream microvessel is associated with loss of microvascular integrity after embolic middle cerebral artery occlusion. Brain Res 2001, 912:181-194.
24. Ritter L.S., Stempel K.M., Coull B.M., McDonagh P.F. Leukocyte-platelet aggregates in rat peripheral blood after ischemic stroke and reperfusion. Biol Res Nurs 2005, 6:281-288.
25. Lo A.C., Chen A.Y., Hung V.K., Yaw L.P., Fung M.K., Ho M.C., Chung S.S., Chung S.K. Endothelin-1 overexpression leads to further water accumulation and brain edema after middle cerebral artery occlusion via aquaporin 4 expression in astrocytic end-feet. J Cereb Blood Flow Metab 2005, 25:998-1011.
26. Lindvall O., Kokaia Z. Recovery and rehabilitation in stroke. Stem cells. Stroke 2004, 35(Suppl 1):2691-2694.
27. Harrison M.J. Neurologic complications of coronary artery bypass grafting: Diffuse or focal ischemia?. Ann Thorac Surg 1995, 59:1356-1358.
28. Fujioka M., Okuchi K., Sakaki T., Hiranatsu K.I., Miyamoto S., Iwasaki S. Specific changes in human brain following reperfusion after cardiac arrest. Stroke 1994, 25:2091-2095.
29. Furlan A.J., Sila C.A., Chimowitz M.I., Jones S.C. Neurological complications related to cardiac surgery. Neurol Clin 1992, 10:145-166.
30. Hamill R.J. Resuscitation: When is enough, enough?. Respir Care 1995, 40:515-524.
31. Taraszewska A., Zelman I.B., Ogonowska W., Chrzanowska H. The pattern of irreversible brain changes after cardiac arrest in humans. Folia Neuropathol 2002, 40:133-141.
32. Takahashi S., Higano S., Ishii K., Matsumoto K., Sakamoto K., Iwasaki Y., Suzuki M. Hypoxic brain damage: Cortical laminar necrosis and delayed changes in white matter at sequential MR imaging. Radiology 1993, 189:449-456.
33. Wisniewski H.M., Maslinska D. Beta-protein immunoreactivity in the human brain after cardiac arrest. Folia Neuropathol 1996, 34:65-71.
34. Skovronsky D.M., Lee V.M.-Y., Pratico D. Amyloid precursor protein and amyloid β peptide in human platelets. J Bio Chem 2001, 276:17036-17043.
35. Di Luca M., Colciaghi F., Pastorino L., Borroni B., Padovani A., Cattabeni F. Platelets as a peripheral district where to study pathogenetic mechanisms of Alzheimer disease: The case of amyloid precursor protein. Eur J Pharmacol 2000, 405:277-283.
36. Lin B., Ginsberg M.D., Busto R., Dietrich W.D. Sequential analysis of subacute and chronic neuronal, astrocytic and microglial alterations after transient global ischemia in rats. Acta Neuropathol 1998, 95:511-523.
37. Lin B., Schmidt-Kastner R., Busto R., Ginsberg M.D. Progressive parenchymal deposition of β-amyloid precursor protein in rat brain following global cerebral ischemia. Acta Neuropathol 1999, 97:359-368.
38. Dietrich W.D., Lin B., Globus M.Y.-T., Green E.J., Ginsberg M.D., Busto R. Effect of delayed MK-801 [Dizocilpine] treatment with or without immediate postischemic hypothermia on chronic neuronal survival after global forebrain ischemia in rats. J Cereb Blood Flow Meteb 1995, 15:960-968.
39. Colborne F., Sutherland G.R., Auer R.N. Electron microscopic evidence against apoptosis as the mechanism of neuronal death in global ischemia. J Neuroscience 1999, 19:4200-4210.
40. Lin B., Ginsberg M.D. The roles of β-amyloid precursor protein and amyloid β peptide in ischemic brain injury. Pharmacology of Cerebral Ischemia 2000 2000, 37-52. Medpharm Scientific Publishers, Stuttgart. J. Krieglstein, S. Klumpp (Eds.).
41. Pluta R., Lossinsky A.S., Walski M., Wisniewski H.M., Mossakowski M.J. Platelet occlusion phenomenon after short- and long-term survival following complete cerebral ischemia in rats produced by cardiac arrest. J Hirnforsch 1994, 35:463-471.
42. Hue Z. Traditional Chinese Medicine, the TCM Textbook for Medical School 1994, People's Health Publisher, Beijing, (in Chinese). 3rd ed.
43. Phillipson J.D. A matter of some sensitivity. Phytochemistry 1995, 38:1319-1343.
44. Huang K.C. Pharmacology of Chinese Herbs 1999, CRC Press LLC, Boca Raton. 2nd ed.
45. Li X., Bai X., Qin L., Huang H., Xiao Z., Gao T. Neuroprotective effects of Buyang huanwu decoction on neuronal injury in hippocampus after transient forebrain ischemia in rats. Neurosci Lett 2003, 346:29-32.
46. Li Y. Medicines to improve circulation and clean out blood stasis. Chinese Medicine Pharmacology 1993, 129-146. Chinese Medicine of China, Beijing, (in Chinese). 2nd ed. Y.K. Li, M.Y. Jiang (Eds.).
47. Akao T., Kawabata K., Yanagisawa E., Ishihara K., Mizuhar Y., Wakui Y., Sakashita Y., Kobashi K. Baicalin, the predominant flavone glucuronide of scutellariae radix, is absorbed from the rat gastrointestinal tract as the aglycone and restored to its original form. J Pharm Pharmacol 2000, 52:1563-1568.
48. Zuo F., Zhou Z.M., Liu M.L. Determination of 14 chemical constituents in the traditional Chinese medicinal preparation Huangqin-Tang by high performance liquid chromatography. Biol Pharm Bull 2001, 24:693-697.
49. Lai M.Y., Hsiu S.L., Chen C.C., Hou Y.C., Chao P.D. Urinary pharmacokinetics of baicalein, wogonin and their glycosides after oral administration of scutellariae radix in human. Biol Pharm Bull 2003, 26:79-83.
50. Chen L.C., Lee M.H., Chou M.H., Lin M.F., Yang L.L. Pharmacokinetic study of paeoniflorin in mice after oral administration of paeoniae radix extract. J Chromatogr B Biomed Sci Appl 1999, 735:33-40.
51. Chen L.C., Chou M.H., Lin M.F., Yang L.L. Pharmacokinetics of paeoniflorin after oral administration of Shao-yao-Gan-chao Tang in mice. Jpn J Pharmacol 2002, 88:250-255.
52. Chen Y.-C., Shen S.-C., Chen L.-G., Lee T.J., Yang L. Wogonin, baicalin, and baicalein inhibition of inducible nitric oxide synthase and cyclooxygenase-2 gene expressions induced by nitric oxide synthase inhibitors and lipopolysaccharide. Biochem Pharmacol 2001, 61:1417-1427.
53. Zhu H., Wang Z., Ma C., Tian J., Fu F., Li C., Guo D., Roeder E., Liu K. Neuroprotective effects of hydroxyl safflower yellow: A in vivo and in vitro studies. Plant Med 2003, 69:429-433.
54. Tsai T.H., Liu S.C., Tsai P.L., Ho L.K., Shum A.Y.C., Chen C.F. The effects of the cyclosporin A, a P-glycoprotein inhibitor, on the pharmacokinetics of baicalein in the rat: A microdialysis study. Br J Pharmacol 2002, 137:1314-1320.
55. Tsai T., Liang C. Pharmacokinetics of tetramethylpyrazine in rat blood and brain using microdialysis. Int J Pharm 2001, 216:61-66.
56. Liang C., Hong C., Chen C., Tsai T. Measurement and pharmacokinetic study of tetramethylpyrazine in rat blood and its regional brain tissue by high-performance liquid chromatography. J Chromotogr B Biomed Sci Appl 1999, 724:303-309.
57. Lai M.Y., Chen C.C., Hsiu S.L., Chao P.D. Analysis and comparison of baicalin, baicalein and wogonin contents in traditional decoctions and commercial extracts of Scutellariae Radix. J Food Drug Analy 2001, 3:145-149.
58. Morris S.M. The genetic toxicology of 5-bromodeoxyuridine in mammalian cells. Mutat Res 1991, 258:161-188.
59. Taupin P. BrdU immunohistochemistry for studying adult neurogenesis: Paradigms, pitfalls, limitations, and validation. Brain Res Rev 2007, 53:198-214.
60. Ley J.J., Vigdorchik A., Belayev L., Zhao W., Busto R., Khoutorova L., Becker D.A., Ginsberg M.D. Stilbazulenyl nitrone, a second-generation azulenyl nitrone antioxidant, confers enduring neuroprotection in experimental focal cerebral ischemia in the rat: Neurobehavior, histopathology, and pharmacokinetics. J Pharmacol 2005, 313:1090-1100.
61. Arvidsson A., Collin T., Kirik D., Kokaia Z., Lindvall O. Neuronal replacement from endogenous precursors in the adult brain after stroke. Nature Medicine 2002, 8:963-970.
62. Braun H., Schäfer K., Höllt V. βIII Tubulin-expressing neurons reveal enhanced neurogenesis in hippocampal and cortical structures after a contusion trauma in rats. J. Neurotrauma, 2002, 19:975-983.
63. Zhang R., Zhang Z., Wang L., Wang Y., Gousev A., Zhang L., Ho K.L., Morshead C., Chopp M. Activated neural stem cells contribute to stroke-induced neurogenesis and neuroblast migration toward the infarct boundary in adult rats. J Cereb Blood Flow Metab 2004, 24:441-448.
64. Nogawa S., Forster C., Zhang F., Nagayama M., Ross M.E., Iadecola C. Interaction between inducible nitric oxide synthase and cyclooxygenase-2 after cerebral ischemia. Proc Natl Acad Sci U S A 1998, 95:10966-10971.
65. Zhao W., Ginsberg M.D., Prado R., Belayev L. Depiction of infarct frequency distribution by computer-assisted image mapping in rat brains with middle cerebral artery occlusion. Comparison of photothrombotic and intraluminal suture models. Stroke, 1996, 27:1112-1117.
66. Yamashita T., Ninomiya M., Acosta P.H., Garcia-Verdugo J.M., Sunabori T., Sakaguchi M., Adachi K., Kojima T., Hirota Y., Kawase T., Araki N., Abe K., Okano H., Sawamoto K. Subventricular zone-derived neuroblasts migrate and differentiate into mature neurons in the post-stroke adult striatum. J Neruoscience 2006, 26:6627-6636.
67. Rosenstein J.M., Krum J.M., Sternbergerrr L.A., Pulley M.T., Sternberger N.H. Immunocytochemical expression of the endothelial barrier antigen (EBA) during brain angiogenesis. Brain Res Dev Brain Res 1992, 66:47-54.
68. Sternberger N., Sternberger L., Kies M.W., Shear C.R. Cell surface endothelial proteins altered in experimental allergic encephalomyelitis. J Neuroimmunol 1989, 21:241-248.
69. Chan P.H. Mitochondrial dysfunction and oxidative stress as determinants of cell death/survival in stroke. Ann NY Acad Sci 2005, 1042:203-209.
70. Iadecola C., Alexander M. Cerebral ischemia and inflammation. Curr Opin Neurol 2001, 14:89-94.
71. Hamada H., Hiramatsu M., Edamatsu R., Mori A. Free radical scavenging action of baicalein. Arch Biochem Biophys 1993, 306:261-266.
72. Okuda S., Saito H., Katsuki H. Arachidonic acid: Toxic and trophic effects on cultured hippocampal neurons. Neuroscience 1994, 63:691-696.
73. Gao D., Sakkurai K., Katoh M., Chen J., Ogiso T. Inhibition of microsomal lipid peroxidation by baicalein: A possible formation of an iron-baicalein complex. Biochem Mol Biol Int 1996, 39:21-25.
74. Shieh D.E., Liu L.T., Lin C.C. Antioxidant and free radical scavenging effects of baicalein, baicalin and wogonin. Anticancer Res 2000, 20:2861-2865.
75. Hsiao G., Chen Y.C., Lin J., Lin K., Chou D., Lin C., Sheu J. Inhibitory mechanisms of tetramethylpyrazine in middle cerebral artery occlusion (MCAO)-induced focal cerebral ischemia in rats. Planta Med 2006, 72:411-417.
76. Choi B.M., Kim H.J., Oh G.S., Pae H.O., Oh H., Jeong S., Kwon T.O., Kim Y.M., Chung H.T. 1,2,3,4,6-Penta-O-galloyl-beta-D-glucose protects rat neuronal cells (Neuro 2A) from hydrogen peroxide-mediated cell death via the induction of heme oxygenase-1. Neurosci Lett 2002, 328:185-189.
77. Zhang Z., Li P., Wang Z., Li P., Zhang W., Sun Z., Zhang X., Wang Y. A comparative study on the individual and combined effects of baicalin and jasminoidin of focal cerebral ischemia-reperfusion injury. Brain Res 2006, 1123:188-195.
78. Cho J., Lee H.K. Wogonin inhibits ischemic brain injury in a rat model of permanent middle cerebral artery occlusion. Biol Pharm Bull 2004, 27:1561-1564.
79. Hsieh C.L., Cheng C.Y., Tsai T.H., Lin I.H., Liu C.H., Chiang S.Y., Lin J.G., Lao C.J., Tang N.Y. Paeonol reduced cerebral infarction involving the superoxide anion and microglia activation in ischemia-reperfusion injured rats. J Ethnopharmacol 2006, 106:208-215.
80. Yang J.W., Ouyang J.P., Liao W.J., Tian J., Liu Y.M., Wei L., Wang B.H., Li K. The effects of Chinese herb angelica in focal cerebral ischemia injury in the rat. Clin Hemorheol Microcirc 2005, 32:209-215.
81. Leung A.W., Mo Z.X., Zheng Y.S. Reduction of cellular damage induced by cerebral ischemia in rats. Neurochem Res 1991, 16:687-692.
82. Romano C., Price M., Bai H.Y., Olney J.W. Neuroprotectants in Honghua: Glucose attenuates retinal ischemic damage. Invest Ophthalmol Vis Sci 1993, 34:72-80.
83. Lee V.M., Pixley S.K. Age and differentiation-related differences in neuron-specific Tubulin immunostaining of olfactory sensory neurons. Brain Res Dev Brain Res 1994, 83:209-215.
84. Kimura Y., Matsushita N., Yokoi-Hayashi K., Okuda H. Effects of baicalein isolated from Scutellaria baicalensis Radix on adhesion molecule expression induced by thrombi and thrombin receptor agonist peptide in cultured human umbilical vein endothelial cells. Planta Med 2001, 67:331-334.
85. Kang D.G., Moon M.K., Choi D.H., Lee J.K., Kwon T.O., Lee H.S. Vasodilatory and anti-inflammatory effects of the 1,2,3,4,6-penta-O-galloyl-beta-D-glucose (PGG) via a nitric oxide-cGMP pathway. Eur J Pharmacol 2005, 524:111-119.
86. Gao D., Song J., Hu J., Lin J., Zheng L., Cai J., Du J., Chen K. Angiogenesis promoting effects of Chinese herbal medicine for activating blood circulation to remove stasis on chick embryo chorio-allantoic membrane. Zhong Xi Jie He Za Zhi 2005, 25:912-915.
87. Lei Y., Wang J.H., Chen K.J. Comparative study on angiogenesis effect of Astragalus membranaceus and Angelica sinensis in chick embryo choriollantoic membrane. Zhongguo Zhong Yao Za Zhi 2003, 28:876-878.
88. Krupinski J., Kaluza J., Kumar P., Kumar S., Wang J.M. Role of angiogenesis in patients with cerebral ischemic stroke. Stroke 1994, 25:1794-1798.
89. Damjanov I. Inflammation. The Pathology for the Health-related Professions 1996, 24-43. W.B. Saunders Co., Philadelphia. I. Damjanov (Ed.).
90. O'Banion M.K. Cyclooxygenase-2: Molecular biology, pharmacology, and neurobiology. Crit Rev Neurobiol 1999, 13:45-82.
91. Hara K., Kong D.L., Sharp F.R., Weinstein P.R. Effect of selective inhibition of cyclooxygenase 2 on temporary focal cerebral ischemia in rats. Neurosci Lett 1998, 256:53-56.
92. Shon Y., Nam K. Protective effect of astragali radix extract on interleukin 1 beta induced inflammation in human amnion. Phytother Res 2003, 17:1016-1020.
93. Gui S., Wei W., Wang H., Wu L., Sun W., Chen W. Effects and mechanisms of crude astragalosides fraction on liver fibrosis in rats. J Ethnopharmacol 2006, 103:154-159.
94. Li B.Q., Fu T., Gong W., Dunlop N., Kung H., Yan Y., Kang J., Wang J.M. The flavonoid baicalin exhibits anti-inflammatory activity by binding to chemokines. Immunopharmacology 2000, 49:295-306.
95. Li F.Q., Wang Z., Liu P.B., Hong J.S. Inhibition of microglial activation by the herbal flavonoid baicalein attenuates inflammation-mediated degeneration of dopaminergic neurons. J Neural Transm 2005, 112:331-347.
96. Nakayama M., Uchimura K., Zhu R.L., Magayama T., Rose M., Stetler R.A., Isakson P.C., Chen J., Graham S.H. Cyclooxygenase-2 inhibition prevents delayed death of CA1 hippocampal neurons following global ischemia. Proc Natl Acad Sci USA 1998, 95:10954-10959.
97. Koistinaho J., Koponen S., Chan P.H. Expression of cyclooxygenase-2 mRNA after global ischemia is regulated by AMPA receptors and glucocorticoids. Stroke 1994, 30:1900-1905.
98. Zhang G.Q., Hao X.M., Chen S.Z., Zhou P.A., Cheng H.P., Wu C.H. Blockade of paeoniflorin on sodium current in mouse hippocampal CA1 neurons. Acta Pharmacol Sinica 2003, 24:1248-1252.
99. Petito C.K., Feldmann E., Pulsinelli W.A., Plum F. Delayed hippocampal damage in humans following cardiorespiratory arrest. Neurology 1987, 37:1281-1286.
100. Lin B., Ginsberg M.D., Busto R. Hyperglycemic exacerbation of neuronal damage following forebrain ischemia: Microglial, astrocytic and endothelial alteration. Acta Neuropathol 1998, 96:610-620.
101. Nogawa S., Zhang F., Ross M.E., Iadecola C. Cyclooxygenase-2 gene expression in neurons contributes to ischemic brain damage. J Neurosci 1997, 17:2746-2755.
102. Iadecola C., Forster C., Nogawa S., Clark H.B., Ross M.E. Cyclo-oxygenase-2 immunoreactivity in the human brain following cerebral ischemia. Acta Neuropathol 1999, 98:9-14.
103. Madrigal J.L., Garcia-Bueno B., Caso J.R., Perez-Nievas B.G., Leza J.C. Stress-induced oxidative changes in brain. CNS Neurol Disord Drug Targets 2006, 5:561-568.
104. Pepicelli O., Fedele E., Bonanno G., Raiteri M., Ajmone-Cat M.A., Greco A., Levi G., Minghetti L. In vivo activation of N-methyl-D-aspartate receptors in the rat hippocampus increases prostaglandin E (2) extracellular levels and triggers lipid peroxidation through cyclooxygenase-mediated mechanisms. J Neurochem 2002, 81:1028-1034.
105. Kim Y.O., Leem K., Park J., Lee P., Ahn D.K., Lee B.C., Park H.K., Suk K., Kim S.Y., Kim H. Cytoprotective effect of Scutellaria baicalensis in CA1 hippocampal neurons of rats after global cerebral ischemia. J Ethnopharmacol 2001, 77:183-188.
106. Chen Y., Yang L., Lee T.J. Oroxylin A inhibition of lipopolysaccharide-induced iNOS and COX-2 gene expression via suppression of nuclear factor-kappaB activation. Biochem Pharmacol 2000, 59:1445-1457.
107. Piao H.Z., Jin S.A., Chun H.S., Lee J.C., Kim W.K. Neuroprotective effect of wogonin: Potential roles of inflammatory cytokines. Arch Pharm Res 2004, 27:930-936.
108. Lee H., Kim Y.O., Kim H., Kim S.Y., Noh H.S., Kang S.S., Cho G.J., Choi W.S., Suk K. Flavonoid wogonin from medicinal herb is neuroprotective by inhibiting inflammatory activation of microglia. FASEB J 2003, 17:1943-1944.
109. Prieto J.M., Recio M.C., Giner R.M., Manez S., Giner-Larza E.M., Rios J.L. Influence of traditional Chinese anti-inflammatory medicinal plants on leukocyte and platelet functions. J Pharm Pharmacol 2003, 55:1275-1282.
110. Sheu J.R., Hsiao G., Lee Y.M., Yen M.H. Antithrombotic effects of tetramethylpyrazine in vivo experiments. Int J Hematol 2001, 73:393-398.
111. Sheu J., Kan Y., Hung W., Ko W., Yen M. Mechanisms involved in the antiplatelet activity of tetramethlpyrazine in human platelets. Thromb Res 1997, 88:259-270.
112. Chen W., Lu Y.P. Shengmai San. Formulae of Chinese Medicine 1993, 200-204. School of Traditional Chinese Medicine of Shanghai, Shanghai. 2nd ed. W. Chen, Y.P. Lu (Eds.).
113. Athanasuleas C.L., Buckberg G.D., Allen B.S., Beyersdorf F., Kirsh M.M. Sudden cardiac death: Directing the scope of resuscitation towards the heart and brain. Resuscitation 2006, 70:44-51.
114. Ichikawa H., Konishi T. In vitro antioxidant potentials of traditional Chinese Medicine, Shengmai San and their relation to in vivo protective effect on cerebral oxidative damage in rats. Biol Pharm Bull 2002, 25:898-903.
115. Ichikawa H., Wang L., Konishi T. Role of component herbs in antioxidant activity of Shengmai San - a traditional Chinese medicine formula preventing cerebral oxidative damage in rat. Am J Chin Med 2003, 31:509-521.
116. Ichikawa H., Wang L., Konishi T. Prevention of cerebral oxidative injury by post-ischemic intravenous administration of Shengmai San. Am J Chin Med 2006, 4:591-600.
117. Watanabe H. Candidates for cognitive enhancer extracted from medicinal plants: Paeoniflorin and tetramethylpyrazine. Behav Brain Res 1997, 83:135-141.
118. Wu W., Qiu F. Experimental study on ischemia and reperfusion injury of rat liver and effects of ligustrazine and salvia compound. Chin Med Sci J 1994, 9:162-166.
119. Hua J., En-tan G. Effect of postoperative treatment with a combination of Chuan Xiong and electrete on functional recovery of muscle grafts: An experimental study in the dog. Plast Reconstr Surg 1996, 98:851-855.
120. Cao W., Zeng Z., Zhu Y., Luo W., Demura H., Naruse M., Shi Y. Effects of tetramethylpyrazine, a Chinese medicine, on plasma endothelin-1 levels during acute pulmonary hypoxia in anesthetized dogs. J Cardiovasc Pharmacol 1998, 31(Suppl 1):S456-S459.
121. Zheng Z., Zhu W., Zhou X., Jin Z., Liu H., Chen X., Pan J., Demura H., Naruse M., Shi Y. Tetramethylpyrazine, a Chinese drug, blocks coronary vasoconstriction by endothelin-1 and decreases plasma endothelin-1 levels in experimental animals. J Cardiovasc Pharmacol. 1998, 31(Suppl 1):S313-S316.
122. Feng J., Liu R., Wu G., Tang S. Effects of tetramethylpyrazine on the release of PGI2 and TXA2 in the hypoxic isolated rat heart. Mol Cell Biochem 1997, 167:153-158.
123. Peng W., Hucks D., Priest R.M., Kan Y.M., Ward J.P. Ligustrazine-induced endothelium-dependent relaxation in pulmonary arteries via a NO-mediated and exogenous L-arginine-dependent mechanism. Br J Pharmacol 1996, 119:1063-1071.
124. Liu C., Hu Y. Anti-inflammatory herbs. Chinese Medicine Pharmacology 1993, 48-78. Chinese Medicine of China, Beijing, (in Chinese). 2nd ed. Y.K. Li, M.Y. Jiang (Eds.).
125. Sheu J., Kan Y., Hung W., Lin C., Yen M. The antiplatelet activity of tetramethylpyrazine is mediated through activation of NO synthase. Life Sci 2000, 67:937-947.
126. Zhang Z., Wei T., Hou J., Li G., Yu S., Xin W. Iron-induced oxidative damage and apoptosis in cerebellar granule cells: Attenuation by tetramethylpyrazine and ferulic acid. Eur J Pharmacol 2003, 467:41-47.
127. Pang P., Shan J., Chiu K. Tetramethylpyrazine, a calcium antagonist. Planta Med 1996, 62:431-435.
128. Ozaki Y. Anti-inflammatory effect of tetramethylpyrazine and ferulic acid. Chem Pharm Bull (Tokyo) 1992, 40:954-956.
129. Xiaohong Y., Jing-Ping O.Y., Shuzheng T. Angelica protects the human vascular endothelial cell from the effects of oxidized low-density lipoprotein in vitro. Clin Hemorheol Microcire 2000, 22:317-323.
130. Rhyu M., Kim J., Kim E. Radix angelica elicits both nitric oxide-dependent and calcium influx-mediated relaxation in rat aorta. J Cardiovasc Pharmacol 2005, 46:99-104.
131. Farooqui A.A., Litsky M.L., Farooqui T., Horrocks L.A. Inhibitors of intracellular phospholipase A2 activity: Their neurochemical effects and therapeutical importance for neurological disorders. Brain Res Bull 1999, 49:139-153.
132. Clemens J.A., Stephenson D.T., Smalstig E.B., Roberts E.F., Johnstone E.M., Sharp J.D., Little S.P., Kramer R.M. Reactive glia express cytosolic phospholipase A2 after transient global forebrain ischemia in rat. Stroke 1996, 27:527-535.
133. Kramer R.M., Stephenson D.T., Roberts E.F., Clemens J.A. Cytosolic phospholipase A2 and lipid mediator release in brain. J Lipid Mediat Cell Signal 1996, 14:3-7.
134. Xue J., Ichikawa H., Konishi T. Antioxidant potential of qizhu tang, a Chinese herbal medicine, and the effect on cerebral oxidative damage after ischemia reperfusion rats. Biol Pharm Bull 2001, 24:558-563.
135. He X., Li C., Yu S. Protective effects of radix astragali against anoxic damages to in vitro cultured neurons. J Tongii Med Univ 2000, 20:126-127.
136. Song Z., Ji Z., Lo C., Dong T., Zhao K., Li O., Haines C., Kung S., Tsim K. Chemical and biological assessment of a traditional Chinese herbal decoction prepared from Radix Astragali and Radix Angelicae sinensis: Orthogonal array design to optimize the extraction of chemical constituents. Planta Med 2004, 70:1222-1227.
137. Zhang H., Nagatsu A., Watanabe T., Sakakibara J., Okuyama H. Antioxidative compounds isolated from safflower (Carthamus tinctorius L.) oil cake. Chem Pharm Bull (Tokyo) 1997, 45:1910-1914.
138. Cai Q., Li X., Wang H. Astragali and angelica protect the kidney against ischemia and reperfusion injury and accelerate recovery. Chin Med J 2001, 114:119-123.
139. Yim T., Wu W., Pak W., Mak D., Liang S., Ko K. Myocardial protection against ischemia-reperfusion injury by a Polygonum multiflrum extract supplemented "Dang-Gui decoction for enriching blood," a compound formulation, ex vivo. Phytotherapy Res 2000, 14:195-199.
140. Lee S.E., Hwang H.J., Ha J.S., Jeong H.S., Kim J.H. Screening of medicinal plant extracts for antioxidant activity. Life Sci 2003, 73:167-179.
141. Lim B.O., Yu B.P., Kim S.C., Park D.K. The antioxidative effect of ganhuangenin against lipid peroxidation. Phytother Res 1999, 13:479-483.
142. You K.M., Jong H.G., Kim H.P. Inhibition of cyclooxygenase/lipoxygenase from human platelets by polyhydroxylated/methoxylated flavonoids isolated from medicinal plants. Arch Pharm Res 1999, 22:18-24.
143. Hanasaki Y., Ogawa S., Fukui S. The correlation between active oxygen scavenging and antioxidative effects of flavonoids. Free Radic Biol Med 1994, 16:845-850.
144. Gao D., Tawa R., Masaki H., Okano Y., Sakurai H. Protective effects of baicalein against cell damage by reactive oxygen species. Chem Pharm Bull (Tokyo) 1998, 46:1383-1387.
145. Gao Z., Huang K., Yang X., Xu H. Protective effects of flavonoids in the roots of Scutellaria baicalensis Georgi against hydrogen peroxide-induced oxidative stress in HS-SY5Y cells. Pharmacol Res 2001, 43:173-178.
146. Morimoto S., Tateishi N., Matsuda T., Tanaka H., Taura F., Furuya N., Matsuyama N., Shoyama Y. Novel hydrogen peroxide metabolism in suspension cells of Scutellaria baicalensis Georgi. J Biol Chem 1998, 273:12601-12611.
147. Gao Z., Huang K., Yang X., Xu H. Free radical scavenging and antioxidant activities of flavonoids extracted from the radix of Scutellaria baicalensis Georgi. Biochim Biophys Acta. 1999, 1472:643-650.
148. Gabrielska J., Oszmianski J., Zylka R., Komorowska M. Antioxidant activity of flavones from Scutellaria baicalensis in lecithin liposomes. Z Naturgorsch [C] 1997, 52:817-823.
149. Yokozawa T., Dong E., Kawai Y., Gemba M., Shimizu M. Protective effects of some flavonoids on the renal cellular membrane. Exp Toxicol Pathol 1999, 51:9-14.
150. 2 in cultured fibroblasts. Biol Pharm Bull 2003, 26:282-284.
151. 2+ elevation by reducing phospholipase C activity in C6 rat glioma cell. J Pharm Pharmacol 1998, 50:1179-1182.
152. Lee H.H., Yang L.L., Wang C.C., Hu S.Y., Chang S.F., Lee Y.H. Differential effects of natural polyphenols on neuronal survival in primary cultured central neurons against glutamate- and glucose deprivation-induced neuronal death. Brain Res 2003, 986:103-113.
153. Son D., Le P., Lee J., Kim H., Kim S.Y. Neuroprotective effect of wogonin in hippocampal slice culture exposed to oxygen and glucose deprivation. Eur J Pharmacol 2004, 493:99-102.
154. Lin C.C., Shieh D.E. The anti-inflammatory activity of Scutellaria rivularis xtracts and its active components, baicalin, baicalein and wogonin. Am J Chin Med 1996, 24:31-36.
155. Nakamura N., Hayasaka S., Zhang X.Y., Nagaki Y., Matsumoto M., Hayasaka Y., Terasawa K. Effects of baicalin, baicalein, and wogonin on interkeukin-6 and interleukin-8 expression and nuclear factor-kappa B binding activities induced by interleukin-1 β in human retinal pigment epithelial cell line. Exp Eye Res 2003, 77:195-202.
156. Zhu M., Rajamani S., Kaylor J., Han S., Zhou F., Fink A. The flavonoid baicalein inhibits fibrillation of α-synuclein and disaggregates existing fibrils. J Bio Chem 2004, 279:26846-26857.
157. Stanke-Labesque F., Devillier P., Bedouch P., Cracowski J.L., Chavanon O., Bessard G. Angiotensin II-induced contractions in human internal mammary artery: Effects of cyclooxygenase and lipoxygenase inhibition. Cardiovasc Res 2000, 47:376-383.
158. Nakahata N., Kutsuwa M., Kyo R., Kubo M., Hayashi K., Ohizumi Y. Analysis of inhibitory effects of scutellariae radix and baicalein on prostaglandin E2 production in rat C6 glioma cells. Am J Chin Med 1998, 26:311-323.
159. Kimura Y., Matsushita N., Okuda H. Effects of baicalein isolated from Scutellaria baicalensis on interleukin 1 beta- and tumor necrosis factor alpha-induced adhesion molecule expression in cultured human umbilical vein endothelial cells. J Ethnopharmacol 1997, 57:63-67.
160. Kimura Y., Okuda H., Ogita Z. Effects of flavonoids isolated from scutellariae radix on fibrinolytic system induced by trypsin in human umbilical vein endothelial cells. J Nat Prod 1997, 60:598-601.
161. Kimura Y., Yokoi K., Matsushita N., Okuda H. Effects of flavonoids isolated from scutellariae radix on the production of tissue-type plasminogen activator and plasminogen activator inhibitor-1 induced by thrombin and thrombin receptor agonist peptide in cultured human umbilical vein endothelial cells. J Pharm Pharmacol 1997, 49:816-822.
162. Lebeau A., Esclaire F., Rostene W., Pelaprat D. Baicalein protects cortical neurons from β amyloid (25-35) induced toxicity. Neuroreport 2001, 12:2199-2202.
163. Heo H.J., Kim D.O., Choi S.J., Shin D.H., Lee C.Y. Potent inhibitory effect of flavonoids in Scutellaria baicalensis on amyloid beta proteins-induced neurotoxicity. J Agric Food Chem 2004, 52:4128-4132.
164. Homma M., Oka K., Taniguchi C., Nitsuma T., Hayashi T. Systematic analysis of post-administrative Saiboku-To urine by liquid chromatography to determine pharmacokinetics of traditional Chinese Medicine. Biomed Chromatogr 1997, 11:125-131.
165. Zhang L., Xing D., Wang W., Wang R., Du L. Kinetic difference of baicalin in rat blood and cerebral nuclei after intravenous administration of scutellariae radix extract. J Ethnopharmacol 2006, 103:120-125.
166. Goto H., Shimada Y., Tanaka N., Tanigawa K., Itoh T., Terasawa K. Effect of extract prepared from the roots of Paeonia lactiflora on endothelium-dependent relaxation and antioxidant enzyme activity in rats administered high-fat diet. Phytother Res 1999, 13:526-528.
167. Yasuda T., Kon R., Nakazawa T., Ohsawa K. Metabolism of paeonol in rats. J Nat Prod 1999, 62:1142-1144.
168. Yan D., Saito K., Ohmi Y., Fujie N., Ohtsuka K. Paeoniflorin, a novel heat shock protein-inducing compound. Cell Stress Chaperones 2004, 9:378-389.
169. Huang M., Tchue Z. Tonics. Chinese Medicine Pharmacology 1993, 177-205. Chinese Medicine of China Press, Beijing, (in Chinese). 2nd ed. Y.K. Li, M.Y. Jiang (Eds.).
170. Oh J.K., Hyun S.Y., Oh H.R., Jung J.W., Park C., Lee S., Park J.H., Kim S.Y., Kim Y.K., Ryu J.H. Effects of Anemarrhena asphodeloides on focal ischemic brain injury induced by middle cerebral artery occlusion in rats. Biol Pharm Bull 2007, 30:38-43.
171. Yu S.J., Kim J.R., Lee C.K., Han J.E., Lee J.H. Gastrodia elata Blume and an active component, p-hydroxybenzyl alcohol, reduce focal ischemic brain injury through antioxidant related gene expressions. Biol Pharm Bull 2005, 28:1016-1020.
172. Kim H., Lee S., Moon K. Ether fraction of methanol extracts of Gastrodia elata, medicinal herb protects against neuronal cell damage after transient global ischemia in gerbils. Phytother Res 2003, 17:909-912.
173. Li L., Zhou Q., Shi J. Protective effects of icariin on neurons injured by cerebral ischemia/reperfusion. Chin Med J. 2005, 118:1637-1643.
174. Joseph J.A., Nadeau D.A., Underwood A. The Color Code, a Revolutionary Eating Plan for Optimum Health 2002, Hyperion, New York. J.A. Joseph, D.A. Nadeau, A. Underwood (Eds.).